2009 Food and Drug Administration Side effects 
World of DTC Marketing
FEBRUARY 4, 2021
Merck’s old drugs are under more scrutiny, and anti-vaxxers are causing problems by cherry-picking unreliable information. regulators knew about reports of suicidal behavior in men taking the anti-baldness treatment Propecia when they decided not to warn consumers of those potential risks in a 2011 update of the popular drug’s label.
Pharma Marketing Network
MARCH 25, 2023
Pharmaceutical advertising is a crucial aspect of promoting and marketing drugs to the public. With the increase in competition, it has become essential for pharmaceutical companies to find the most effective methods of advertisement to reach their target audience. “Direct-to-Consumer Advertising of Prescription Drugs.”
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
European Pharmaceutical Review
SEPTEMBER 22, 2023
Limitations of monoclonal antibody therapies Regulatory approvals from the US Food and Drug Administration (FDA) for aducanumab and lecanemab – and likely very soon for donanemab also – opened a route for different therapeutic modalities and other relevant disease targets, such as tau. Lowe SL, Duggan Evans C, et al.
Healthcare Success
OCTOBER 17, 2024
Lee Aase: But we came up with a strategy, and then we just sort of nudged our way into things over time and then around 2009, just based on some of the success we'd seen with some of the YouTube videos we'd done and some of those other projects. I'm like, it's controlled drugs. Stewart Gandolf: and I had a new primary care, doctor.
Pharma Marketing Network
JUNE 11, 2020
So, this was back in 2009, and I hosted a Halloween party at my house, and I decided to dress up as Hunter S. You know, in November 2009, the FDA held a public hearing about the promotion of Food and Drug Administrative Related Regulated Medical Products, using the internet and social media tools.
Expert insights. Personalized for you.
180 
Let's personalize your content